Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Cisplatin/Irinotecan and Radiotherapy in Locally Advanced Esophageal Cancer
NCT00213486Phase 2Completed
- Sponsor
- Rouen University Hospital
- Start
- Jan 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan in esophageal cancer, sponsored by Rouen University Hospital. Primary endpoint: Clinical Complete Response. Started Jan 2003; status: completed.
02
Drugs
irinotecan
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00213486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213486.